|
|
|
|
|
|
Assistant Secretary for Planning and Evaluation |
|
[ Full Table of Contents ] [ Printer Friendly Version in PDF Format ]
Date: August 26, 2005
To: Jim J. Tozzi, Center for Regulatory Effectiveness
Re: June 24, 2005, Request for Reconsideration submitted by the Center for Regulatory Effectiveness on Atrazine
Dear Mr. Tozzi:
Your request for reconsideration under the National Institutes of Health Guidelines for Ensuring the Quality of Information Disseminated to the Public, submitted on behalf of the Center for Regulatory Effectiveness is still under review. While our goal is to respond within 60 days to such requests, we are unable to do so in this case. We anticipate that a response providing the Agency’s views will be forwarded to you by October 26, 2005.
Thank you for your interest in the quality of information disseminated by NIH. Should you have any questions, please contact me on 301-594-2464.
Sincerely,
Lora Kutkat, Office of Science Policy and Planning Office of the Director National Institutes of Health
cc: B. Greenberg, DHHS; M. Wolfe, NIEHS, NTP